Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zymeworks Inc. (ZYME) Institutional Ownership & Insider Trading

203 institutions reported holding Zymeworks Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 11 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZYMEZymeworks Inc.Follow ZYME — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

203 institutions held 98.1% of the shares. Across filers that reported both quarters, shares held changed -0.9%.

Increased+54New+21Decreased-66Closed-24

Largest moves, shares (millions)

Assenagon Asset Management…+1.8MNomura Asset Management…+0.9MPerceptive Advisors+0.7MMpm Bioimpact-0.6MNuveen-0.5MDeutsche Bank Ag\-0.5M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-5.9Sep 24-0.2Dec 24+4.1Mar 25+5.2Jun 25-1.8Sep 25-1.1Dec 25-1.1Mar 26-0.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2620370-0.9%54216624
Mar 2621070-1.7%74324833
Dec 2520471-1.6%68375819
Sep 2518074-2.3%54225319
Jun 2518076+7.6%56265026
Mar 2518170+6.3%53265916
Dec 2417166-0.3%45215816
Sep 2416166-8.7%38194921

Zymeworks Inc. — questions

Who owns Zymeworks Inc. stock?
203 institutions reported Zymeworks Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: EcoR1 Capital, LLC (32.4%), Rubric Capital Management LP (9.9%), BlackRock, Inc. (6.0%).
Are Zymeworks Inc. insiders buying or selling?
11 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Zymeworks Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.